Vaxcyte 公司
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership32,233 shares
Latest Disclosed Value $ 1,047,250
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 9.48% decrease in ownership of PCVX / Vaxcyte, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 32,233 shares of Vaxcyte, Inc. (US:PCVX) valued at $1,047,250 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 35,609 shares of Vaxcyte, Inc.. This represents a change in shares of -9.48% during the quarter. The current value of the position is $1,526,555 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP VAXCYTE EC US92243G1085 32,233 -3,376 -9.48 1,047 -59.73 0.0138
2025-04-25 2025-02-28 NP VAXCYTE EC US92243G1085 35,609 9,371 35.72 2,600 5.05 0.0350
2025-01-27 2024-11-30 NP VAXCYTE EC US92243G1085 26,238 -2,458 -8.57 2,475 6.82 0.0336
2024-10-29 2024-08-31 NP VAXCYTE EC US92243G1085 28,696 3,578 14.24 2,317 31.27 0.0343
2024-07-26 2024-05-31 NP VAXCYTE EC US92243G1085 25,118 325 1.31 1,765 -3.55 0.0280
2024-04-24 2024-02-29 NP VAXCYTE EC US92243G1085 24,793 403 1.65 1,830 45.01 0.0306
2024-01-24 2023-11-30 NP VAXCYTE EC US92243G1085 24,390 39 0.16 1,263 -0.16 0.0242
2023-10-27 2023-08-31 NP VAXCYTE EC US92243G1085 24,351 390 1.63 1,264 6.58 0.0247
2023-07-26 2023-05-31 NP VAXCYTE EC US92243G1085 23,961 78 0.33 1,187 21.27 0.0256
2023-04-27 2023-02-28 NP VAXCYTE EC US92243G1085 23,883 585 2.51 978 -8.85 0.0239
2023-01-26 2022-11-30 NP VAXCYTE EC US92243G1085 23,298 611 2.69 1,073 80.94 0.0268
2022-10-26 2022-08-31 NP VAXCYTE EC US92243G1085 22,687 -26,194 -53.59 593 -49.40 0.0148
2022-07-29 2022-05-31 NP VAXCYTE EC US92243G1085 48,881 11,166 29.61 1,173 34.25 0.0299
2022-04-28 2022-02-28 NP VAXCYTE EC US92243G1085 37,715 598 1.61 874 15.48 0.0202
2022-01-25 2021-11-30 NP VAXCYTE EC US92243G1085 37,117 989 2.74 756 -20.17 0.0158
2021-10-26 2021-08-31 NP VAXCYTE EC US92243G1085 36,128 17,340 92.29 948 139.75 0.0208
2021-07-22 2021-05-31 NP VAXCYTE EC US92243G1085 18,788 72 0.38 396 -10.23 0.0098
2021-04-23 2021-02-28 NP VAXCYTE EC US92243G1085 18,716 18,217 3,650.70 441 2,650.00 0.0115
2021-01-20 2020-11-30 NP VAXCYTE EC US92243G1085 499 499 16 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.